TSXV:TRL.H - Post by User
Post by
LTOWNERon Aug 08, 2012 9:08am
294 Views
Post# 20193219
Q4 Partnership?
Q4 Partnership? Both management and the RBC analyst appear to assume a partnership "event" will be announced in Q4. I believe the word "products" (i.e. plural) were mentioned in conjunction with this partnering event, which may or may not mean Compleo and Tefina are to be linked. Soon after the 'event', development of an asthma product is to begin. Management calls past quarter "exciting and productive" in terms of moving toward an NDA to the FDA for Compleo.
The market for Testosterone continues to grow and is now projected to be US $5 Billion by 2017. It is one of the fastest growing markets in the US. Lilly is currently "creating noise" to influence this growth in the marketplace and Androgel is now Abbott's 3rd largest product.